[HTML][HTML] Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules

GF Papadaki, O Ani, TJ Florio, MC Young… - Frontiers in …, 2023 - frontiersin.org
Major Histocompatibility Complex class I (MHC-I) molecules display self, viral or aberrant
epitopic peptides to T cell receptors (TCRs), which employ interactions between …

Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules

GF Papadaki, O Ani, TJ Florio… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Major Histocompatibility Complex class I (MHC-I) molecules display self, viral or aberrant
epitopic peptides to T cell receptors (TCRs), which employ interactions between …

[引用][C] Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules

GF Papadaki, O Ani, TJ Florio, MC Young… - … in Immunology (Web), 2023 - jglobal.jst.go.jp
Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I
molecules | Article Information | J-GLOBAL Art J-GLOBAL ID:202302241001641286 …

Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules

G Papadaki, O Ani, T Florio, M Young… - Frontiers in …, 2023 - europepmc.org
Abstract Major Histocompatibility Complex class I (MHC-I) molecules display self, viral or
aberrant epitopic peptides to T cell receptors (TCRs), which employ interactions between …

Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules

G Papadaki, O Ani, T Florio, M Young… - The Journal of …, 2023 - journals.aai.org
Human leucocyte antigens (HLAs) display a repertoire of epitopic peptides on the cell
surface for T cell recognition. Amino acid polymorphisms in the peptide-binding groove of …

[PDF][PDF] Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules

GF Papadaki, O Ani, TJ Florio, MC Young, JN Danon… - 2023 - researchgate.net
The class I proteins of the Major Histocompatibility Complex (MHC-I) present epitopic
peptide antigens on the cell surface, thereby enabling immune surveillance of the …

[HTML][HTML] Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules

GF Papadaki, O Ani, TJ Florio, MC Young… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Abstract Major Histocompatibility Complex class I (MHC-I) molecules display self, viral or
aberrant epitopic peptides to T cell receptors (TCRs), which employ interactions between …

[PDF][PDF] Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules

GF Papadaki, O Ani, TJ Florio, MC Young, JN Danon… - 2023 - researchgate.net
The class I proteins of the Major Histocompatibility Complex (MHC-I) present epitopic
peptide antigens on the cell surface, thereby enabling immune surveillance of the …

Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules.

GF Papadaki, O Ani, TJ Florio, MC Young… - Frontiers in …, 2023 - europepmc.org
Major Histocompatibility Complex class I (MHC-I) molecules display self, viral or aberrant
epitopic peptides to T cell receptors (TCRs), which employ interactions between …